Skeletal muscle insulin resistance in prediabetes: a lipidomic perspective on diacylglycerols, ceramides, and phospholipids

. 2025 Nov 05 ; 15 (1) : 38784. [epub] 20251105

Jazyk angličtina Země Anglie, Velká Británie Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid41193613

Grantová podpora
IGA_LF_2025_009 Palacky University, Olomouc
LM2023052 CZ-OPENSCREEN
LM2023053 EATRIS-CZ
IKEM, IN 00023001 Ministry of Health of the Czech Republic

Odkazy

PubMed 41193613
PubMed Central PMC12589396
DOI 10.1038/s41598-025-22745-1
PII: 10.1038/s41598-025-22745-1
Knihovny.cz E-zdroje

Lipid metabolism disorders, accompanied by the accumulation of lipids, are believed to contribute to skeletal muscle insulin resistance development. These alterations may attenuate insulin signaling and glucose uptake and utilization. However, the specific roles of individual lipids remain incompletely understood. The study examined the relationship between skeletal muscle lipid composition and insulin resistance in a non-obese prediabetic hereditary hypertriglyceridemic (HHTg) rats. Male HHTg rats aged 4 and 12 months, exhibiting insulin resistance, and dyslipidaemia were used in this study. Skeletal muscle lipidomic profiles were analyzed using tandem mass spectrometry. Compared to age-matched Wistar controls, HHTg rats exhibited increased serum triglycerides, elevated NEFA and impaired glucose tolerance. Impaired muscle insulin sensitivity in HHTg rats was associated with the accumulation of triglycerides and 1,3-diacylglycerols, and most notably with an increase in specific ceramide species (18:0, 22:0, 24:0, 24:1) in both 4- and 12-month-old animals. Elevated mRNA expression of Degs1, a key enzyme in ceramide biosynthesis, may underlie the observed ceramide accumulation. Lipidomic profiling revealed decreases in membrane phospholipids, including phosphatidylethanolamine (PE 41:2), lysophosphatidylcholine (LPC 22:6), and lysophosphatidylethanolamine (LPE 20:0). In HHTg prediabetic model, skeletal muscle insulin resistance develops independently of obesity and prior to diabetes onset, driven by the accumulation of lipotoxic diacylglycerols and ceramides, alongside a reduction in specific phospholipids and lysophospholipids. Impaired fatty acid oxidation and enhanced ceramide biosynthesis contribute to ectopic lipid deposition, with ceramides exerting a more pronounced effect on insulin signaling. Strain-specific alterations in lipid metabolism are more significant than age-related alterations.

Zobrazit více v PubMed

DeFronzo, R. A. & Tripathy, D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. PubMed PMC

Brechtel, K. et al. Fast elevation of the intramyocellular lipid content in the presence of Circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. PubMed

Leonard, B. L., Watson, R. N., Loomes, K. M., Phillips, A. R. & Cooper, G. J. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. PubMed

Divisova, J., Kazdova, L., Hubova, M. & Meschisvili, E. Relationship between insulin resistance and muscle triglyceride content in Nonobese and obese experimental models of insulin resistance syndrome. PubMed

Jacob, S. et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. PubMed

Yang, Q., Vijayakumar, A. & Kahn, B. B. Metabolites as regulators of insulin sensitivity and metabolism. PubMed PMC

Broskey, N. T., Obanda, D. N., Burton, J. H., Cefalu, W. T. & Ravussin, E. Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes. PubMed PMC

Tonks, K. T. et al. Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans. PubMed PMC

Preuss, C. et al. A new targeted lipidomics approach reveals lipid droplets in liver, muscle and heart as a repository for Diacylglycerol and ceramide species in Non-Alcoholic fatty liver. PubMed PMC

Gautam, J. et al. Characterization of lipid signatures in the plasma and insulin-sensitive tissues of the C57BL/6J mice fed on obesogenic diets. PubMed

Zicha, J. et al. Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome? PubMed

Vrana, A. & Kazdova, L. The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. PubMed

Malinska, H., Huttl, M., Oliyarnyk, O., Bratova, M. & Kazdova, L. Conjugated Linoleic acid reduces visceral and ectopic lipid accumulation and insulin resistance in chronic severe hypertriacylglycerolemia. PubMed

Neckar, J. et al. Increased expression and altered subcellular distribution of PKC-delta in chronically hypoxic rat myocardium: involvement in cardioprotection. PubMed

Markova, I. et al. Long-term Pioglitazone treatment augments insulin sensitivity and PKC-epsilon and PKC-theta activation in skeletal muscles in sucrose fed rats. PubMed

Peterson, G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. PubMed

Duchoslav, E. & Burton, L. Molecular characterization and quantification of lipids with high resolution accurate mass tandem MS techniques. Biomarkers and omics. AB Sciex Technical Note. 2021;RUO-MKT-02-13720-A (2021).

Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between Raw spectra and functional insights. PubMed PMC

Markova, I. et al. The effect of lipotoxicity on renal dysfunction in a Nonobese rat model of metabolic syndrome: A urinary proteomic approach. PubMed PMC

Turner, N., Cooney, G. J., Kraegen, E. W. & Bruce, C. R. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. PubMed

Kelley, D. E. & Goodpaster, B. H. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. PubMed

Roden, M. & Shulman, G. I. The integrative biology of type 2 diabetes. PubMed

Morino, K., Petersen, K. F. & Shulman, G. I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. PubMed PMC

Sokolowska, E. & Blachnio-Zabielska, A. The role of ceramides in insulin resistance. PubMed PMC

Samuel, V. T. & Shulman, G. I. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. PubMed PMC

Bell, K. S. et al. Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-theta localization. PubMed

Yu, C. et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. PubMed

Kolczynska, K., Loza-Valdes, A., Hawro, I. & Sumara, G. Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review. PubMed PMC

Chauhan, V. P., Chauhan, A., Deshmukh, D. S. & Brockerhoff, H. Lipid activators of protein kinase C. PubMed

Petersen, M. C. et al. Effect of weight loss on skeletal muscle bioactive lipids in people with obesity and type 2 diabetes. PubMed PMC

Takagi, H. et al. Acetyl-CoA carboxylase 2 Inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats. PubMed

Chung, J. O., Koutsari, C., Blachnio-Zabielska, A. U., Hames, K. C. & Jensen, M. D. Intramyocellular ceramides: subcellular concentrations and fractional de Novo synthesis in postabsorptive humans. PubMed PMC

Shimabukuro, M. et al. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of Serine palmitoyltransferase overexpression. PubMed

Bergman, B. C. et al. Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans. PubMed

Chaurasia, B. et al. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. PubMed PMC

Holland, W. L. et al. Lipid-induced insulin resistance mediated by the Proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. PubMed PMC

Gilbert, M. Role of skeletal muscle lipids in the pathogenesis of insulin resistance of obesity and type 2 diabetes. PubMed PMC

Chen, Z. et al. The potential function and clinical application of FGF21 in metabolic diseases. PubMed PMC

Paoletti, I., Coccurello, R. & Irisin A multifaceted hormone bridging exercise and disease pathophysiology. PubMed PMC

Holland, W. L. et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. PubMed PMC

Pierucci, F., Chirco, A. & Meacci, E. Irisin is target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated signaling in skeletal muscle cells. PubMed PMC

Izumiya, Y. et al. FGF21 is an Akt-regulated myokine. PubMed PMC

Vessby, B., Tengblad, S. & Lithell, H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. PubMed

Storlien, L. H. et al. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. PubMed

Heden, T. D., Neufer, P. D. & Funai, K. Looking beyond structure: membrane phospholipids of skeletal muscle mitochondria. PubMed PMC

Pilon, M. Revisiting the membrane-centric view of diabetes. PubMed PMC

Paran, C. W. et al. Reduced efficiency of sarcolipin-dependent respiration in myocytes from humans with severe obesity. PubMed PMC

Lee, S. et al. Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men. PubMed PMC

Ferrara, P. J. et al. Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle. PubMed PMC

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...